奥马珠单抗用于治疗囊性纤维化患者的ABPA加重期。 - Suppr

Omalizumab for treatment of ABPA exacerbations in CF patients.

作者信息

Lebecque Patrick, Leonard Anissa, Pilette Charles

出版信息

Pediatr Pulmonol. 2009 May;44(5):516. doi: 10.1002/ppul.21002.

DOI:10.1002/ppul.21002

PMID:19382216

Abstract

摘要

相似文献

Omalizumab for treatment of ABPA exacerbations in CF patients.

Pediatr Pulmonol. 2009 May;44(5):516. doi: 10.1002/ppul.21002.

Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach.

J Asthma. 2009 Jun;46(5):445-7. doi: 10.1080/02770900902849871.

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).

Pediatr Pulmonol. 2008 Dec;43(12):1249-51. doi: 10.1002/ppul.20907.

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.

Pediatr Pulmonol. 2008 Jun;43(6):607-10. doi: 10.1002/ppul.20804.

Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.

Pediatr Pulmonol. 2014 May;49(5):503-7. doi: 10.1002/ppul.22937. Epub 2013 Oct 25.

Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.

Allergy. 2010 Jan;65(1):134-5. doi: 10.1111/j.1398-9995.2009.02147.x.

Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.

Paediatr Respir Rev. 2013 Mar;14(1):22-4. doi: 10.1016/j.prrv.2012.11.004. Epub 2013 Jan 1.

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.

Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.

Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Ther Adv Respir Dis. 2014 Oct;8(5):141-9. doi: 10.1177/1753465814547517. Epub 2014 Aug 21.

引用本文的文献

Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.

Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.

Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review.

Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0011-2022. Print 2022 Sep 30.

Omalizumab, an anti-immunoglobulin E antibody: state of the art.

Drug Des Devel Ther. 2014 Feb 7;8:197-207. doi: 10.2147/DDDT.S49409. eCollection 2014.

Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab.

J Asthma Allergy. 2012;5:65-70. doi: 10.2147/JAA.S34579. Epub 2012 Nov 8.

Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin e therapy (omalizumab).

J Pediatr Pharmacol Ther. 2012 Jan;17(1):88-92. doi: 10.5863/1551-6776-17.1.88.

Severe asthma with fungal sensitization.

Curr Allergy Asthma Rep. 2011 Oct;11(5):403-13. doi: 10.1007/s11882-011-0217-4.

Omalizumab: Anti-IgE therapy in allergy.

Curr Allergy Asthma Rep. 2011 Apr;11(2):101-6. doi: 10.1007/s11882-010-0173-4.

Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Int J Pediatr. 2010;2010:376287. doi: 10.1155/2010/376287. Epub 2010 Dec 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Omalizumab for treatment of ABPA exacerbations in CF patients.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献